Overview

Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
This study was designed to evaluate the efficacy of delafloxacin patients with acute bacterial skin and soft tissue infections (ABSSSI).
Phase:
Phase 3
Details
Lead Sponsor:
Melinta Therapeutics, Inc.
Treatments:
Aztreonam
Fluoroquinolones
Vancomycin